Loading organizations...
Loading organizations...
Biopharmaceutical company developing targeted molecular immunotherapies.
GlobeImmune has raised $17.5M across 1 funding round.
GlobeImmune has raised $17.5M in total across 1 funding round.
GlobeImmune has raised $17.5M in total across 1 funding round.
GlobeImmune's investors include BSI, Generali.
GlobeImmune has raised $17.5M across 1 funding round. Most recently, it raised $17.5M Series E in January 2010.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jan 19, 2010 | $17.5M Series E | BSI, Generali |